Incidence of Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (IPNSAE)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03957616|
Recruitment Status : Not yet recruiting
First Posted : May 21, 2019
Last Update Posted : May 21, 2019
|Condition or disease|
|Paraneoplastic Neurological Syndrome Autoimmune Encephalitis|
|Study Type :||Observational|
|Estimated Enrollment :||600 participants|
|Official Title:||Incidence of Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis in France Between 2016 and 2018|
|Estimated Study Start Date :||May 30, 2019|
|Estimated Primary Completion Date :||May 30, 2019|
|Estimated Study Completion Date :||July 31, 2019|
Paraneoplastic neurological syndromes patients
Patients tested for Paraneoplastic neurological syndromes (PNS) and Autoimmune Encephalitis (AE) with a lumbar puncture, with detection of an antibody or negative, but with PNS clinically diagnosed.
- Incidence and prevalence of diagnosed Paraneoplastic Neurological Syndromes (PNS) and Autoimmune Encephalitis (AE) between 2016 and 2018. [ Time Frame: 3 years ]Comparison between general population of the French counties and the cohort of PNS to calculate incidence and prevalence.
- Location (city) of diagnosis [ Time Frame: 1 hour ]Name of city where the diagnosis of Paraneoplastic Neurological Syndromes (PNS) or Autoimmune Encephalitis (AE) was made.
- French general population of each counties [ Time Frame: 3 years ]Person years for each region
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03957616
|Contact: Géraldine Picard||4 72 35 58 42 ext email@example.com|
|Contact: Jérôme Honnorat||4 72 35 78 06 ext firstname.lastname@example.org|
|Centre de référence des syndromes neurologiques paranéoplasiques et encéphalites auto-immunes||Active, not recruiting|
|Lyon, France, 69003|
|Principal Investigator:||Jérôme Honnorat||center for paraneoplastic neurological syndromes and autoimmune encephalitis|